nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—epilepsy syndrome	0.541	1	CbGaD
Amiloride—ASIC2—ganglion—epilepsy syndrome	0.00808	0.1	CbGeAlD
Amiloride—ASIC1—ganglion—epilepsy syndrome	0.00511	0.0635	CbGeAlD
Amiloride—ASIC2—forebrain—epilepsy syndrome	0.00339	0.0421	CbGeAlD
Amiloride—ASIC2—telencephalon—epilepsy syndrome	0.00312	0.0387	CbGeAlD
Amiloride—ASIC2—medulla oblongata—epilepsy syndrome	0.00245	0.0304	CbGeAlD
Amiloride—SCNN1D—forebrain—epilepsy syndrome	0.00218	0.0271	CbGeAlD
Amiloride—ASIC1—forebrain—epilepsy syndrome	0.00214	0.0266	CbGeAlD
Amiloride—SCNN1D—telencephalon—epilepsy syndrome	0.00201	0.025	CbGeAlD
Amiloride—ASIC1—telencephalon—epilepsy syndrome	0.00197	0.0245	CbGeAlD
Amiloride—ASIC2—head—epilepsy syndrome	0.00194	0.0241	CbGeAlD
Amiloride—SLC9A1—telencephalon—epilepsy syndrome	0.00189	0.0235	CbGeAlD
Amiloride—ASIC2—nervous system—epilepsy syndrome	0.00184	0.0229	CbGeAlD
Amiloride—ASIC2—central nervous system—epilepsy syndrome	0.00177	0.022	CbGeAlD
Amiloride—ASIC2—cerebellum—epilepsy syndrome	0.00173	0.0215	CbGeAlD
Amiloride—SCNN1A—telencephalon—epilepsy syndrome	0.00157	0.0195	CbGeAlD
Amiloride—SLC22A1—ganglion—epilepsy syndrome	0.00155	0.0193	CbGeAlD
Amiloride—ASIC1—medulla oblongata—epilepsy syndrome	0.00155	0.0193	CbGeAlD
Amiloride—ASIC1—midbrain—epilepsy syndrome	0.00142	0.0176	CbGeAlD
Amiloride—ASIC2—brain—epilepsy syndrome	0.00141	0.0175	CbGeAlD
Amiloride—ASIC1—spinal cord—epilepsy syndrome	0.00138	0.0172	CbGeAlD
Amiloride—SLC9A1—midbrain—epilepsy syndrome	0.00136	0.0169	CbGeAlD
Amiloride—SCNN1D—head—epilepsy syndrome	0.00125	0.0155	CbGeAlD
Amiloride—ASIC1—head—epilepsy syndrome	0.00123	0.0153	CbGeAlD
Amiloride—SCNN1D—nervous system—epilepsy syndrome	0.00119	0.0147	CbGeAlD
Amiloride—SLC9A1—head—epilepsy syndrome	0.00118	0.0146	CbGeAlD
Amiloride—ASIC1—nervous system—epilepsy syndrome	0.00116	0.0145	CbGeAlD
Amiloride—SCNN1D—central nervous system—epilepsy syndrome	0.00114	0.0142	CbGeAlD
Amiloride—ASIC1—central nervous system—epilepsy syndrome	0.00112	0.0139	CbGeAlD
Amiloride—SCNN1G—cerebellum—epilepsy syndrome	0.00112	0.0139	CbGeAlD
Amiloride—SCNN1D—cerebellum—epilepsy syndrome	0.00112	0.0139	CbGeAlD
Amiloride—SLC9A1—nervous system—epilepsy syndrome	0.00111	0.0139	CbGeAlD
Amiloride—PLAU—head—epilepsy syndrome	0.00111	0.0139	CbGeAlD
Amiloride—ASIC1—cerebellum—epilepsy syndrome	0.00109	0.0136	CbGeAlD
Amiloride—SLC9A1—central nervous system—epilepsy syndrome	0.00107	0.0133	CbGeAlD
Amiloride—PLAU—nervous system—epilepsy syndrome	0.00106	0.0131	CbGeAlD
Amiloride—SCNN1B—head—epilepsy syndrome	0.00106	0.0131	CbGeAlD
Amiloride—SLC9A1—cerebellum—epilepsy syndrome	0.00105	0.013	CbGeAlD
Amiloride—PLAU—central nervous system—epilepsy syndrome	0.00102	0.0126	CbGeAlD
Amiloride—SCNN1B—nervous system—epilepsy syndrome	0.001	0.0125	CbGeAlD
Amiloride—SCNN1A—head—epilepsy syndrome	0.000976	0.0121	CbGeAlD
Amiloride—SCNN1B—central nervous system—epilepsy syndrome	0.000964	0.012	CbGeAlD
Amiloride—SCNN1D—brain—epilepsy syndrome	0.000906	0.0113	CbGeAlD
Amiloride—ASIC1—brain—epilepsy syndrome	0.000889	0.0111	CbGeAlD
Amiloride—SLC9A1—brain—epilepsy syndrome	0.000852	0.0106	CbGeAlD
Amiloride—PLAU—brain—epilepsy syndrome	0.000807	0.01	CbGeAlD
Amiloride—SCNN1B—brain—epilepsy syndrome	0.000765	0.00952	CbGeAlD
Amiloride—SCNN1A—brain—epilepsy syndrome	0.000707	0.00879	CbGeAlD
Amiloride—SLC22A1—forebrain—epilepsy syndrome	0.00065	0.00808	CbGeAlD
Amiloride—SLC22A1—telencephalon—epilepsy syndrome	0.000598	0.00743	CbGeAlD
Amiloride—SLC22A4—spinal cord—epilepsy syndrome	0.00044	0.00547	CbGeAlD
Amiloride—SLC22A1—head—epilepsy syndrome	0.000372	0.00463	CbGeAlD
Amiloride—SLC22A1—nervous system—epilepsy syndrome	0.000353	0.00439	CbGeAlD
Amiloride—SLC22A4—cerebellum—epilepsy syndrome	0.000349	0.00434	CbGeAlD
Amiloride—SLC22A1—central nervous system—epilepsy syndrome	0.00034	0.00423	CbGeAlD
Amiloride—SLC22A4—brain—epilepsy syndrome	0.000283	0.00352	CbGeAlD
Amiloride—SLC22A1—brain—epilepsy syndrome	0.00027	0.00335	CbGeAlD
Amiloride—Dizziness—Levetiracetam—epilepsy syndrome	0.000113	0.000553	CcSEcCtD
Amiloride—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000113	0.000553	CcSEcCtD
Amiloride—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000113	0.000553	CcSEcCtD
Amiloride—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000113	0.000553	CcSEcCtD
Amiloride—Back pain—Pregabalin—epilepsy syndrome	0.000113	0.000552	CcSEcCtD
Amiloride—Cough—Valproic Acid—epilepsy syndrome	0.000112	0.000551	CcSEcCtD
Amiloride—Vomiting—Propofol—epilepsy syndrome	0.000112	0.000551	CcSEcCtD
Amiloride—Muscle spasms—Pregabalin—epilepsy syndrome	0.000112	0.000549	CcSEcCtD
Amiloride—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000112	0.000549	CcSEcCtD
Amiloride—Pruritus—Diazepam—epilepsy syndrome	0.000112	0.000548	CcSEcCtD
Amiloride—Rash—Propofol—epilepsy syndrome	0.000111	0.000546	CcSEcCtD
Amiloride—Dermatitis—Propofol—epilepsy syndrome	0.000111	0.000546	CcSEcCtD
Amiloride—Headache—Propofol—epilepsy syndrome	0.000111	0.000543	CcSEcCtD
Amiloride—Vomiting—Midazolam—epilepsy syndrome	0.00011	0.000539	CcSEcCtD
Amiloride—Diarrhoea—Vigabatrin—epilepsy syndrome	0.00011	0.000539	CcSEcCtD
Amiloride—Asthenia—Felbamate—epilepsy syndrome	0.00011	0.000538	CcSEcCtD
Amiloride—Chest pain—Valproic Acid—epilepsy syndrome	0.00011	0.000537	CcSEcCtD
Amiloride—Arthralgia—Valproic Acid—epilepsy syndrome	0.00011	0.000537	CcSEcCtD
Amiloride—Tremor—Pregabalin—epilepsy syndrome	0.000109	0.000535	CcSEcCtD
Amiloride—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000109	0.000534	CcSEcCtD
Amiloride—Rash—Midazolam—epilepsy syndrome	0.000109	0.000534	CcSEcCtD
Amiloride—Dizziness—Fosphenytoin—epilepsy syndrome	0.000109	0.000534	CcSEcCtD
Amiloride—Dermatitis—Midazolam—epilepsy syndrome	0.000109	0.000534	CcSEcCtD
Amiloride—Vomiting—Levetiracetam—epilepsy syndrome	0.000109	0.000532	CcSEcCtD
Amiloride—Alopecia—Gabapentin—epilepsy syndrome	0.000108	0.000531	CcSEcCtD
Amiloride—Headache—Midazolam—epilepsy syndrome	0.000108	0.000531	CcSEcCtD
Amiloride—Pruritus—Felbamate—epilepsy syndrome	0.000108	0.000531	CcSEcCtD
Amiloride—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000108	0.00053	CcSEcCtD
Amiloride—Diarrhoea—Diazepam—epilepsy syndrome	0.000108	0.00053	CcSEcCtD
Amiloride—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000108	0.00053	CcSEcCtD
Amiloride—Rash—Levetiracetam—epilepsy syndrome	0.000108	0.000528	CcSEcCtD
Amiloride—Dermatitis—Levetiracetam—epilepsy syndrome	0.000108	0.000527	CcSEcCtD
Amiloride—Asthenia—Zonisamide—epilepsy syndrome	0.000107	0.000527	CcSEcCtD
Amiloride—Headache—Levetiracetam—epilepsy syndrome	0.000107	0.000524	CcSEcCtD
Amiloride—Dizziness—Vigabatrin—epilepsy syndrome	0.000106	0.000521	CcSEcCtD
Amiloride—Confusional state—Valproic Acid—epilepsy syndrome	0.000106	0.00052	CcSEcCtD
Amiloride—Pruritus—Zonisamide—epilepsy syndrome	0.000106	0.000519	CcSEcCtD
Amiloride—Flatulence—Gabapentin—epilepsy syndrome	0.000105	0.000516	CcSEcCtD
Amiloride—Bradycardia—Topiramate—epilepsy syndrome	0.000105	0.000515	CcSEcCtD
Amiloride—Nausea—Propofol—epilepsy syndrome	0.000105	0.000514	CcSEcCtD
Amiloride—Tension—Gabapentin—epilepsy syndrome	0.000105	0.000514	CcSEcCtD
Amiloride—Vomiting—Fosphenytoin—epilepsy syndrome	0.000105	0.000513	CcSEcCtD
Amiloride—Diarrhoea—Felbamate—epilepsy syndrome	0.000105	0.000513	CcSEcCtD
Amiloride—Vertigo—Pregabalin—epilepsy syndrome	0.000105	0.000513	CcSEcCtD
Amiloride—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000105	0.000513	CcSEcCtD
Amiloride—Dizziness—Diazepam—epilepsy syndrome	0.000105	0.000512	CcSEcCtD
Amiloride—Rash—Fosphenytoin—epilepsy syndrome	0.000104	0.000509	CcSEcCtD
Amiloride—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000104	0.000509	CcSEcCtD
Amiloride—Haemoglobin—Topiramate—epilepsy syndrome	0.000104	0.000508	CcSEcCtD
Amiloride—Nervousness—Gabapentin—epilepsy syndrome	0.000104	0.000508	CcSEcCtD
Amiloride—Asthenia—Clonazepam—epilepsy syndrome	0.000104	0.000508	CcSEcCtD
Amiloride—Back pain—Gabapentin—epilepsy syndrome	0.000103	0.000506	CcSEcCtD
Amiloride—Headache—Fosphenytoin—epilepsy syndrome	0.000103	0.000506	CcSEcCtD
Amiloride—Haemorrhage—Topiramate—epilepsy syndrome	0.000103	0.000506	CcSEcCtD
Amiloride—Palpitations—Pregabalin—epilepsy syndrome	0.000103	0.000504	CcSEcCtD
Amiloride—Asthenia—Phenytoin—epilepsy syndrome	0.000103	0.000504	CcSEcCtD
Amiloride—Nausea—Midazolam—epilepsy syndrome	0.000103	0.000503	CcSEcCtD
Amiloride—Muscle spasms—Gabapentin—epilepsy syndrome	0.000103	0.000503	CcSEcCtD
Amiloride—Diarrhoea—Zonisamide—epilepsy syndrome	0.000102	0.000502	CcSEcCtD
Amiloride—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000102	0.000502	CcSEcCtD
Amiloride—Pruritus—Clonazepam—epilepsy syndrome	0.000102	0.000501	CcSEcCtD
Amiloride—Vomiting—Vigabatrin—epilepsy syndrome	0.000102	0.000501	CcSEcCtD
Amiloride—Cough—Pregabalin—epilepsy syndrome	0.000102	0.000498	CcSEcCtD
Amiloride—Pruritus—Phenytoin—epilepsy syndrome	0.000101	0.000497	CcSEcCtD
Amiloride—Nausea—Levetiracetam—epilepsy syndrome	0.000101	0.000497	CcSEcCtD
Amiloride—Rash—Vigabatrin—epilepsy syndrome	0.000101	0.000496	CcSEcCtD
Amiloride—Dizziness—Felbamate—epilepsy syndrome	0.000101	0.000496	CcSEcCtD
Amiloride—Dermatitis—Vigabatrin—epilepsy syndrome	0.000101	0.000496	CcSEcCtD
Amiloride—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000101	0.000495	CcSEcCtD
Amiloride—Headache—Vigabatrin—epilepsy syndrome	0.000101	0.000493	CcSEcCtD
Amiloride—Vomiting—Diazepam—epilepsy syndrome	0.000101	0.000493	CcSEcCtD
Amiloride—Anorexia—Valproic Acid—epilepsy syndrome	0.0001	0.000491	CcSEcCtD
Amiloride—Tremor—Gabapentin—epilepsy syndrome	0.0001	0.00049	CcSEcCtD
Amiloride—Rash—Diazepam—epilepsy syndrome	9.97e-05	0.000489	CcSEcCtD
Amiloride—Dermatitis—Diazepam—epilepsy syndrome	9.96e-05	0.000488	CcSEcCtD
Amiloride—Visual impairment—Topiramate—epilepsy syndrome	9.94e-05	0.000487	CcSEcCtD
Amiloride—Arthralgia—Pregabalin—epilepsy syndrome	9.91e-05	0.000486	CcSEcCtD
Amiloride—Chest pain—Pregabalin—epilepsy syndrome	9.91e-05	0.000486	CcSEcCtD
Amiloride—Dizziness—Zonisamide—epilepsy syndrome	9.9e-05	0.000486	CcSEcCtD
Amiloride—Headache—Diazepam—epilepsy syndrome	9.9e-05	0.000485	CcSEcCtD
Amiloride—Diarrhoea—Clonazepam—epilepsy syndrome	9.88e-05	0.000484	CcSEcCtD
Amiloride—Asthenia—Carbamazepine—epilepsy syndrome	9.82e-05	0.000481	CcSEcCtD
Amiloride—Diarrhoea—Phenytoin—epilepsy syndrome	9.81e-05	0.000481	CcSEcCtD
Amiloride—Nausea—Fosphenytoin—epilepsy syndrome	9.79e-05	0.00048	CcSEcCtD
Amiloride—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.76e-05	0.000478	CcSEcCtD
Amiloride—Vomiting—Felbamate—epilepsy syndrome	9.73e-05	0.000477	CcSEcCtD
Amiloride—Pruritus—Carbamazepine—epilepsy syndrome	9.68e-05	0.000475	CcSEcCtD
Amiloride—Rash—Felbamate—epilepsy syndrome	9.65e-05	0.000473	CcSEcCtD
Amiloride—Dermatitis—Felbamate—epilepsy syndrome	9.64e-05	0.000472	CcSEcCtD
Amiloride—Tinnitus—Topiramate—epilepsy syndrome	9.62e-05	0.000472	CcSEcCtD
Amiloride—Vertigo—Gabapentin—epilepsy syndrome	9.59e-05	0.00047	CcSEcCtD
Amiloride—Headache—Felbamate—epilepsy syndrome	9.59e-05	0.00047	CcSEcCtD
Amiloride—Confusional state—Pregabalin—epilepsy syndrome	9.58e-05	0.00047	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.58e-05	0.000469	CcSEcCtD
Amiloride—Dizziness—Clonazepam—epilepsy syndrome	9.55e-05	0.000468	CcSEcCtD
Amiloride—Nausea—Vigabatrin—epilepsy syndrome	9.54e-05	0.000468	CcSEcCtD
Amiloride—Vomiting—Zonisamide—epilepsy syndrome	9.52e-05	0.000467	CcSEcCtD
Amiloride—Insomnia—Valproic Acid—epilepsy syndrome	9.51e-05	0.000466	CcSEcCtD
Amiloride—Asthenia—Lamotrigine—epilepsy syndrome	9.49e-05	0.000465	CcSEcCtD
Amiloride—Dizziness—Phenytoin—epilepsy syndrome	9.48e-05	0.000465	CcSEcCtD
Amiloride—Rash—Zonisamide—epilepsy syndrome	9.44e-05	0.000463	CcSEcCtD
Amiloride—Paraesthesia—Valproic Acid—epilepsy syndrome	9.44e-05	0.000463	CcSEcCtD
Amiloride—Palpitations—Gabapentin—epilepsy syndrome	9.44e-05	0.000463	CcSEcCtD
Amiloride—Dermatitis—Zonisamide—epilepsy syndrome	9.44e-05	0.000463	CcSEcCtD
Amiloride—Dizziness—Oxcarbazepine—epilepsy syndrome	9.43e-05	0.000462	CcSEcCtD
Amiloride—Nausea—Diazepam—epilepsy syndrome	9.39e-05	0.00046	CcSEcCtD
Amiloride—Headache—Zonisamide—epilepsy syndrome	9.38e-05	0.00046	CcSEcCtD
Amiloride—Dyspnoea—Valproic Acid—epilepsy syndrome	9.37e-05	0.000459	CcSEcCtD
Amiloride—Diarrhoea—Carbamazepine—epilepsy syndrome	9.36e-05	0.000459	CcSEcCtD
Amiloride—Pruritus—Lamotrigine—epilepsy syndrome	9.36e-05	0.000459	CcSEcCtD
Amiloride—Shock—Pregabalin—epilepsy syndrome	9.35e-05	0.000458	CcSEcCtD
Amiloride—Somnolence—Valproic Acid—epilepsy syndrome	9.34e-05	0.000458	CcSEcCtD
Amiloride—Cough—Gabapentin—epilepsy syndrome	9.32e-05	0.000457	CcSEcCtD
Amiloride—Dyspepsia—Valproic Acid—epilepsy syndrome	9.25e-05	0.000454	CcSEcCtD
Amiloride—Vomiting—Clonazepam—epilepsy syndrome	9.18e-05	0.00045	CcSEcCtD
Amiloride—Decreased appetite—Valproic Acid—epilepsy syndrome	9.14e-05	0.000448	CcSEcCtD
Amiloride—Alopecia—Topiramate—epilepsy syndrome	9.12e-05	0.000447	CcSEcCtD
Amiloride—Vomiting—Phenytoin—epilepsy syndrome	9.12e-05	0.000447	CcSEcCtD
Amiloride—Rash—Clonazepam—epilepsy syndrome	9.1e-05	0.000446	CcSEcCtD
Amiloride—Dermatitis—Clonazepam—epilepsy syndrome	9.09e-05	0.000446	CcSEcCtD
Amiloride—Arthralgia—Gabapentin—epilepsy syndrome	9.09e-05	0.000446	CcSEcCtD
Amiloride—Chest pain—Gabapentin—epilepsy syndrome	9.09e-05	0.000446	CcSEcCtD
Amiloride—Nausea—Felbamate—epilepsy syndrome	9.09e-05	0.000446	CcSEcCtD
Amiloride—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	9.08e-05	0.000445	CcSEcCtD
Amiloride—Vomiting—Oxcarbazepine—epilepsy syndrome	9.07e-05	0.000445	CcSEcCtD
Amiloride—Fatigue—Valproic Acid—epilepsy syndrome	9.06e-05	0.000444	CcSEcCtD
Amiloride—Anorexia—Pregabalin—epilepsy syndrome	9.06e-05	0.000444	CcSEcCtD
Amiloride—Dizziness—Carbamazepine—epilepsy syndrome	9.05e-05	0.000444	CcSEcCtD
Amiloride—Diarrhoea—Lamotrigine—epilepsy syndrome	9.05e-05	0.000444	CcSEcCtD
Amiloride—Headache—Clonazepam—epilepsy syndrome	9.04e-05	0.000443	CcSEcCtD
Amiloride—Rash—Phenytoin—epilepsy syndrome	9.04e-05	0.000443	CcSEcCtD
Amiloride—Dermatitis—Phenytoin—epilepsy syndrome	9.03e-05	0.000443	CcSEcCtD
Amiloride—Rash—Oxcarbazepine—epilepsy syndrome	8.99e-05	0.000441	CcSEcCtD
Amiloride—Constipation—Valproic Acid—epilepsy syndrome	8.99e-05	0.000441	CcSEcCtD
Amiloride—Pain—Valproic Acid—epilepsy syndrome	8.99e-05	0.000441	CcSEcCtD
Amiloride—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.98e-05	0.00044	CcSEcCtD
Amiloride—Headache—Phenytoin—epilepsy syndrome	8.98e-05	0.00044	CcSEcCtD
Amiloride—Headache—Oxcarbazepine—epilepsy syndrome	8.94e-05	0.000438	CcSEcCtD
Amiloride—Nausea—Zonisamide—epilepsy syndrome	8.9e-05	0.000436	CcSEcCtD
Amiloride—Flatulence—Topiramate—epilepsy syndrome	8.85e-05	0.000434	CcSEcCtD
Amiloride—Tension—Topiramate—epilepsy syndrome	8.81e-05	0.000432	CcSEcCtD
Amiloride—Confusional state—Gabapentin—epilepsy syndrome	8.79e-05	0.000431	CcSEcCtD
Amiloride—Dizziness—Lamotrigine—epilepsy syndrome	8.75e-05	0.000429	CcSEcCtD
Amiloride—Nervousness—Topiramate—epilepsy syndrome	8.72e-05	0.000428	CcSEcCtD
Amiloride—Vomiting—Carbamazepine—epilepsy syndrome	8.7e-05	0.000427	CcSEcCtD
Amiloride—Back pain—Topiramate—epilepsy syndrome	8.69e-05	0.000426	CcSEcCtD
Amiloride—Feeling abnormal—Valproic Acid—epilepsy syndrome	8.66e-05	0.000425	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.66e-05	0.000424	CcSEcCtD
Amiloride—Muscle spasms—Topiramate—epilepsy syndrome	8.64e-05	0.000423	CcSEcCtD
Amiloride—Rash—Carbamazepine—epilepsy syndrome	8.63e-05	0.000423	CcSEcCtD
Amiloride—Dermatitis—Carbamazepine—epilepsy syndrome	8.62e-05	0.000423	CcSEcCtD
Amiloride—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.6e-05	0.000421	CcSEcCtD
Amiloride—Insomnia—Pregabalin—epilepsy syndrome	8.6e-05	0.000421	CcSEcCtD
Amiloride—Nausea—Clonazepam—epilepsy syndrome	8.57e-05	0.00042	CcSEcCtD
Amiloride—Headache—Carbamazepine—epilepsy syndrome	8.57e-05	0.00042	CcSEcCtD
Amiloride—Shock—Gabapentin—epilepsy syndrome	8.57e-05	0.00042	CcSEcCtD
Amiloride—Paraesthesia—Pregabalin—epilepsy syndrome	8.53e-05	0.000418	CcSEcCtD
Amiloride—Nausea—Phenytoin—epilepsy syndrome	8.52e-05	0.000417	CcSEcCtD
Amiloride—Dyspnoea—Pregabalin—epilepsy syndrome	8.47e-05	0.000415	CcSEcCtD
Amiloride—Nausea—Oxcarbazepine—epilepsy syndrome	8.47e-05	0.000415	CcSEcCtD
Amiloride—Somnolence—Pregabalin—epilepsy syndrome	8.45e-05	0.000414	CcSEcCtD
Amiloride—Tremor—Topiramate—epilepsy syndrome	8.42e-05	0.000413	CcSEcCtD
Amiloride—Vomiting—Lamotrigine—epilepsy syndrome	8.41e-05	0.000412	CcSEcCtD
Amiloride—Rash—Lamotrigine—epilepsy syndrome	8.34e-05	0.000409	CcSEcCtD
Amiloride—Dermatitis—Lamotrigine—epilepsy syndrome	8.33e-05	0.000408	CcSEcCtD
Amiloride—Abdominal pain—Valproic Acid—epilepsy syndrome	8.31e-05	0.000407	CcSEcCtD
Amiloride—Anorexia—Gabapentin—epilepsy syndrome	8.31e-05	0.000407	CcSEcCtD
Amiloride—Headache—Lamotrigine—epilepsy syndrome	8.29e-05	0.000406	CcSEcCtD
Amiloride—Decreased appetite—Pregabalin—epilepsy syndrome	8.26e-05	0.000405	CcSEcCtD
Amiloride—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	8.2e-05	0.000402	CcSEcCtD
Amiloride—Fatigue—Pregabalin—epilepsy syndrome	8.19e-05	0.000402	CcSEcCtD
Amiloride—Nausea—Carbamazepine—epilepsy syndrome	8.13e-05	0.000399	CcSEcCtD
Amiloride—Constipation—Pregabalin—epilepsy syndrome	8.13e-05	0.000398	CcSEcCtD
Amiloride—Pain—Pregabalin—epilepsy syndrome	8.13e-05	0.000398	CcSEcCtD
Amiloride—Vertigo—Topiramate—epilepsy syndrome	8.07e-05	0.000396	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.94e-05	0.000389	CcSEcCtD
Amiloride—Palpitations—Topiramate—epilepsy syndrome	7.94e-05	0.000389	CcSEcCtD
Amiloride—Insomnia—Gabapentin—epilepsy syndrome	7.88e-05	0.000386	CcSEcCtD
Amiloride—Nausea—Lamotrigine—epilepsy syndrome	7.86e-05	0.000385	CcSEcCtD
Amiloride—Cough—Topiramate—epilepsy syndrome	7.84e-05	0.000384	CcSEcCtD
Amiloride—Feeling abnormal—Pregabalin—epilepsy syndrome	7.83e-05	0.000384	CcSEcCtD
Amiloride—Paraesthesia—Gabapentin—epilepsy syndrome	7.82e-05	0.000384	CcSEcCtD
Amiloride—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.77e-05	0.000381	CcSEcCtD
Amiloride—Dyspnoea—Gabapentin—epilepsy syndrome	7.77e-05	0.000381	CcSEcCtD
Amiloride—Somnolence—Gabapentin—epilepsy syndrome	7.75e-05	0.00038	CcSEcCtD
Amiloride—Dyspepsia—Gabapentin—epilepsy syndrome	7.67e-05	0.000376	CcSEcCtD
Amiloride—Arthralgia—Topiramate—epilepsy syndrome	7.65e-05	0.000375	CcSEcCtD
Amiloride—Chest pain—Topiramate—epilepsy syndrome	7.65e-05	0.000375	CcSEcCtD
Amiloride—Decreased appetite—Gabapentin—epilepsy syndrome	7.58e-05	0.000371	CcSEcCtD
Amiloride—Asthenia—Valproic Acid—epilepsy syndrome	7.54e-05	0.00037	CcSEcCtD
Amiloride—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.52e-05	0.000369	CcSEcCtD
Amiloride—Fatigue—Gabapentin—epilepsy syndrome	7.51e-05	0.000368	CcSEcCtD
Amiloride—Abdominal pain—Pregabalin—epilepsy syndrome	7.51e-05	0.000368	CcSEcCtD
Amiloride—Constipation—Gabapentin—epilepsy syndrome	7.45e-05	0.000365	CcSEcCtD
Amiloride—Pain—Gabapentin—epilepsy syndrome	7.45e-05	0.000365	CcSEcCtD
Amiloride—Pruritus—Valproic Acid—epilepsy syndrome	7.44e-05	0.000365	CcSEcCtD
Amiloride—Confusional state—Topiramate—epilepsy syndrome	7.39e-05	0.000362	CcSEcCtD
Amiloride—Shock—Topiramate—epilepsy syndrome	7.21e-05	0.000354	CcSEcCtD
Amiloride—Diarrhoea—Valproic Acid—epilepsy syndrome	7.19e-05	0.000353	CcSEcCtD
Amiloride—Feeling abnormal—Gabapentin—epilepsy syndrome	7.18e-05	0.000352	CcSEcCtD
Amiloride—Gastrointestinal pain—Gabapentin—epilepsy syndrome	7.13e-05	0.000349	CcSEcCtD
Amiloride—Anorexia—Topiramate—epilepsy syndrome	6.99e-05	0.000343	CcSEcCtD
Amiloride—Dizziness—Valproic Acid—epilepsy syndrome	6.95e-05	0.000341	CcSEcCtD
Amiloride—Abdominal pain—Gabapentin—epilepsy syndrome	6.89e-05	0.000338	CcSEcCtD
Amiloride—Asthenia—Pregabalin—epilepsy syndrome	6.82e-05	0.000334	CcSEcCtD
Amiloride—Pruritus—Pregabalin—epilepsy syndrome	6.72e-05	0.00033	CcSEcCtD
Amiloride—Vomiting—Valproic Acid—epilepsy syndrome	6.68e-05	0.000328	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.68e-05	0.000327	CcSEcCtD
Amiloride—Insomnia—Topiramate—epilepsy syndrome	6.63e-05	0.000325	CcSEcCtD
Amiloride—Rash—Valproic Acid—epilepsy syndrome	6.63e-05	0.000325	CcSEcCtD
Amiloride—Dermatitis—Valproic Acid—epilepsy syndrome	6.62e-05	0.000325	CcSEcCtD
Amiloride—Headache—Valproic Acid—epilepsy syndrome	6.59e-05	0.000323	CcSEcCtD
Amiloride—Paraesthesia—Topiramate—epilepsy syndrome	6.58e-05	0.000323	CcSEcCtD
Amiloride—Dyspnoea—Topiramate—epilepsy syndrome	6.54e-05	0.00032	CcSEcCtD
Amiloride—Somnolence—Topiramate—epilepsy syndrome	6.52e-05	0.000319	CcSEcCtD
Amiloride—Diarrhoea—Pregabalin—epilepsy syndrome	6.5e-05	0.000319	CcSEcCtD
Amiloride—Dyspepsia—Topiramate—epilepsy syndrome	6.45e-05	0.000316	CcSEcCtD
Amiloride—Decreased appetite—Topiramate—epilepsy syndrome	6.37e-05	0.000312	CcSEcCtD
Amiloride—Gastrointestinal disorder—Topiramate—epilepsy syndrome	6.33e-05	0.00031	CcSEcCtD
Amiloride—Fatigue—Topiramate—epilepsy syndrome	6.32e-05	0.00031	CcSEcCtD
Amiloride—Dizziness—Pregabalin—epilepsy syndrome	6.28e-05	0.000308	CcSEcCtD
Amiloride—Constipation—Topiramate—epilepsy syndrome	6.27e-05	0.000307	CcSEcCtD
Amiloride—Pain—Topiramate—epilepsy syndrome	6.27e-05	0.000307	CcSEcCtD
Amiloride—Asthenia—Gabapentin—epilepsy syndrome	6.25e-05	0.000306	CcSEcCtD
Amiloride—Nausea—Valproic Acid—epilepsy syndrome	6.24e-05	0.000306	CcSEcCtD
Amiloride—Pruritus—Gabapentin—epilepsy syndrome	6.17e-05	0.000302	CcSEcCtD
Amiloride—Vomiting—Pregabalin—epilepsy syndrome	6.04e-05	0.000296	CcSEcCtD
Amiloride—Feeling abnormal—Topiramate—epilepsy syndrome	6.04e-05	0.000296	CcSEcCtD
Amiloride—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.99e-05	0.000294	CcSEcCtD
Amiloride—Rash—Pregabalin—epilepsy syndrome	5.99e-05	0.000294	CcSEcCtD
Amiloride—Dermatitis—Pregabalin—epilepsy syndrome	5.99e-05	0.000293	CcSEcCtD
Amiloride—Diarrhoea—Gabapentin—epilepsy syndrome	5.96e-05	0.000292	CcSEcCtD
Amiloride—Headache—Pregabalin—epilepsy syndrome	5.95e-05	0.000292	CcSEcCtD
Amiloride—Abdominal pain—Topiramate—epilepsy syndrome	5.8e-05	0.000284	CcSEcCtD
Amiloride—Dizziness—Gabapentin—epilepsy syndrome	5.76e-05	0.000282	CcSEcCtD
Amiloride—Nausea—Pregabalin—epilepsy syndrome	5.64e-05	0.000277	CcSEcCtD
Amiloride—Vomiting—Gabapentin—epilepsy syndrome	5.54e-05	0.000272	CcSEcCtD
Amiloride—Rash—Gabapentin—epilepsy syndrome	5.49e-05	0.000269	CcSEcCtD
Amiloride—Dermatitis—Gabapentin—epilepsy syndrome	5.49e-05	0.000269	CcSEcCtD
Amiloride—Headache—Gabapentin—epilepsy syndrome	5.46e-05	0.000268	CcSEcCtD
Amiloride—Asthenia—Topiramate—epilepsy syndrome	5.26e-05	0.000258	CcSEcCtD
Amiloride—Pruritus—Topiramate—epilepsy syndrome	5.19e-05	0.000254	CcSEcCtD
Amiloride—Nausea—Gabapentin—epilepsy syndrome	5.18e-05	0.000254	CcSEcCtD
Amiloride—Diarrhoea—Topiramate—epilepsy syndrome	5.02e-05	0.000246	CcSEcCtD
Amiloride—Dizziness—Topiramate—epilepsy syndrome	4.85e-05	0.000238	CcSEcCtD
Amiloride—Vomiting—Topiramate—epilepsy syndrome	4.66e-05	0.000228	CcSEcCtD
Amiloride—Rash—Topiramate—epilepsy syndrome	4.62e-05	0.000227	CcSEcCtD
Amiloride—Dermatitis—Topiramate—epilepsy syndrome	4.62e-05	0.000226	CcSEcCtD
Amiloride—Headache—Topiramate—epilepsy syndrome	4.59e-05	0.000225	CcSEcCtD
Amiloride—Nausea—Topiramate—epilepsy syndrome	4.35e-05	0.000213	CcSEcCtD
Amiloride—SLC9A1—Disease—NOS1—epilepsy syndrome	2.59e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	2.58e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	2.58e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	2.56e-05	0.000147	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	2.56e-05	0.000147	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	2.52e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GABBR1—epilepsy syndrome	2.5e-05	0.000143	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CHRNB2—epilepsy syndrome	2.47e-05	0.000142	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HBEGF—epilepsy syndrome	2.47e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	2.47e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	2.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIA1—epilepsy syndrome	2.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIN2A—epilepsy syndrome	2.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—SLC6A1—epilepsy syndrome	2.44e-05	0.00014	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2D6—epilepsy syndrome	2.43e-05	0.000139	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT3—epilepsy syndrome	2.42e-05	0.000139	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—epilepsy syndrome	2.42e-05	0.000138	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	2.41e-05	0.000138	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ADAM10—epilepsy syndrome	2.37e-05	0.000136	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	2.35e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA13—epilepsy syndrome	2.35e-05	0.000134	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.32e-05	0.000133	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ADRA2A—epilepsy syndrome	2.31e-05	0.000133	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CHRNB2—epilepsy syndrome	2.31e-05	0.000132	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—BCHE—epilepsy syndrome	2.3e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	2.3e-05	0.000132	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	2.27e-05	0.00013	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.25e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—CHRNA4—epilepsy syndrome	2.25e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.24e-05	0.000128	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDC42—epilepsy syndrome	2.21e-05	0.000127	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SLC2A1—epilepsy syndrome	2.2e-05	0.000126	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA13—epilepsy syndrome	2.19e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.18e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.18e-05	0.000125	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLCB1—epilepsy syndrome	2.17e-05	0.000125	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TH—epilepsy syndrome	2.17e-05	0.000124	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.15e-05	0.000123	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—CHRNA4—epilepsy syndrome	2.09e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	2.09e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOD—epilepsy syndrome	2.09e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.08e-05	0.000119	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	2.03e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	2.03e-05	0.000116	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HES1—epilepsy syndrome	2.02e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	2e-05	0.000115	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.99e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.99e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.99e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.99e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—BCHE—epilepsy syndrome	1.98e-05	0.000114	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FYN—epilepsy syndrome	1.97e-05	0.000113	CbGpPWpGaD
Amiloride—SLC9A1—Disease—H2AFX—epilepsy syndrome	1.96e-05	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	1.94e-05	0.000111	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—DLG4—epilepsy syndrome	1.93e-05	0.000111	CbGpPWpGaD
Amiloride—SLC9A1—Disease—YWHAZ—epilepsy syndrome	1.89e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—GRIN2B—epilepsy syndrome	1.89e-05	0.000108	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PLCB1—epilepsy syndrome	1.87e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	1.86e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	1.86e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	1.86e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	1.86e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	1.86e-05	0.000107	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.85e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BCHE—epilepsy syndrome	1.85e-05	0.000106	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CCR5—epilepsy syndrome	1.82e-05	0.000104	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—epilepsy syndrome	1.81e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—DLG4—epilepsy syndrome	1.8e-05	0.000103	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAT—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CERS1—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADK—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GLUD1—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PDXK—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FAR1—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—L2HGDH—epilepsy syndrome	1.78e-05	0.000102	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.77e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.77e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—GRIN2B—epilepsy syndrome	1.76e-05	0.000101	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.75e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.74e-05	9.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PLCB1—epilepsy syndrome	1.74e-05	9.98e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—epilepsy syndrome	1.74e-05	9.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	1.73e-05	9.9e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SRC—epilepsy syndrome	1.71e-05	9.79e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.7e-05	9.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.7e-05	9.72e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—TSC2—epilepsy syndrome	1.69e-05	9.69e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—epilepsy syndrome	1.66e-05	9.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADK—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PDXK—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CERS1—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—L2HGDH—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GLUD1—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FAR1—epilepsy syndrome	1.66e-05	9.5e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—epilepsy syndrome	1.66e-05	9.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	1.65e-05	9.45e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.63e-05	9.35e-05	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	1.63e-05	9.34e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GAMT—epilepsy syndrome	1.63e-05	9.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PNPO—epilepsy syndrome	1.63e-05	9.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NHLRC1—epilepsy syndrome	1.63e-05	9.32e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—EPM2A—epilepsy syndrome	1.63e-05	9.32e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	1.62e-05	9.31e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPX1—epilepsy syndrome	1.61e-05	9.25e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	1.58e-05	9.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.58e-05	9.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.58e-05	9.04e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6ST—epilepsy syndrome	1.55e-05	8.91e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS2—epilepsy syndrome	1.54e-05	8.84e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	1.52e-05	8.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	1.52e-05	8.71e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NHLRC1—epilepsy syndrome	1.52e-05	8.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—EPM2A—epilepsy syndrome	1.52e-05	8.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PNPO—epilepsy syndrome	1.52e-05	8.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GAMT—epilepsy syndrome	1.52e-05	8.69e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—QDPR—epilepsy syndrome	1.51e-05	8.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA4—epilepsy syndrome	1.51e-05	8.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.51e-05	8.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	1.47e-05	8.42e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	1.47e-05	8.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	1.47e-05	8.4e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COX3—epilepsy syndrome	1.42e-05	8.15e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—epilepsy syndrome	1.41e-05	8.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—QDPR—epilepsy syndrome	1.41e-05	8.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA4—epilepsy syndrome	1.41e-05	8.08e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.41e-05	8.07e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.41e-05	8.05e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—epilepsy syndrome	1.39e-05	7.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	1.37e-05	7.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CACNA2D2—epilepsy syndrome	1.35e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—KCNB1—epilepsy syndrome	1.35e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PFKL—epilepsy syndrome	1.35e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLCO1A2—epilepsy syndrome	1.35e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC6A8—epilepsy syndrome	1.35e-05	7.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COX3—epilepsy syndrome	1.32e-05	7.59e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.31e-05	7.51e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.29e-05	7.37e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGF2—epilepsy syndrome	1.26e-05	7.21e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLCO1A2—epilepsy syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—KCNB1—epilepsy syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CACNA2D2—epilepsy syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PFKL—epilepsy syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC6A8—epilepsy syndrome	1.26e-05	7.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.25e-05	7.18e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UPB1—epilepsy syndrome	1.23e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ATIC—epilepsy syndrome	1.23e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NEU1—epilepsy syndrome	1.23e-05	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.2e-05	6.86e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—POMC—epilepsy syndrome	1.19e-05	6.83e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HSD17B4—epilepsy syndrome	1.19e-05	6.8e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.17e-05	6.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UPB1—epilepsy syndrome	1.15e-05	6.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ATIC—epilepsy syndrome	1.15e-05	6.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NEU1—epilepsy syndrome	1.15e-05	6.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP1R3C—epilepsy syndrome	1.15e-05	6.57e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GBE1—epilepsy syndrome	1.15e-05	6.57e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTOR—epilepsy syndrome	1.14e-05	6.56e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—epilepsy syndrome	1.13e-05	6.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCB—epilepsy syndrome	1.12e-05	6.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD17B4—epilepsy syndrome	1.11e-05	6.34e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—epilepsy syndrome	1.09e-05	6.22e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ASAH1—epilepsy syndrome	1.08e-05	6.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP1R3C—epilepsy syndrome	1.07e-05	6.12e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GBE1—epilepsy syndrome	1.07e-05	6.12e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.06e-05	6.1e-05	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—epilepsy syndrome	1.06e-05	6.09e-05	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.06e-05	6.08e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—STXBP1—epilepsy syndrome	1.05e-05	6.01e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCB—epilepsy syndrome	1.05e-05	6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NT5E—epilepsy syndrome	1.02e-05	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALAD—epilepsy syndrome	1.02e-05	5.85e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.02e-05	5.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ASAH1—epilepsy syndrome	1e-05	5.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	9.92e-06	5.69e-05	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	9.87e-06	5.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—STXBP1—epilepsy syndrome	9.77e-06	5.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CACNA1A—epilepsy syndrome	9.74e-06	5.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH7A1—epilepsy syndrome	9.74e-06	5.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ST3GAL3—epilepsy syndrome	9.53e-06	5.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALAD—epilepsy syndrome	9.52e-06	5.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NT5E—epilepsy syndrome	9.52e-06	5.46e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—epilepsy syndrome	9.5e-06	5.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	9.47e-06	5.43e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADSL—epilepsy syndrome	9.34e-06	5.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	9.2e-06	5.27e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SRC—epilepsy syndrome	9.17e-06	5.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GLUL—epilepsy syndrome	9.16e-06	5.25e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CACNA1A—epilepsy syndrome	9.08e-06	5.2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH7A1—epilepsy syndrome	9.08e-06	5.2e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CACNA1D—epilepsy syndrome	8.99e-06	5.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ST3GAL3—epilepsy syndrome	8.89e-06	5.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADSL—epilepsy syndrome	8.71e-06	4.99e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GLUL—epilepsy syndrome	8.54e-06	4.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TXNRD1—epilepsy syndrome	8.41e-06	4.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CACNA1D—epilepsy syndrome	8.38e-06	4.8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.36e-06	4.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.28e-06	4.75e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AQP1—epilepsy syndrome	8.16e-06	4.68e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	8.02e-06	4.6e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TXNRD1—epilepsy syndrome	7.84e-06	4.49e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	7.79e-06	4.46e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	7.72e-06	4.42e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AQP1—epilepsy syndrome	7.61e-06	4.36e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	7.48e-06	4.28e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CHRM3—epilepsy syndrome	7.38e-06	4.23e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—KCNJ11—epilepsy syndrome	7.38e-06	4.23e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CHRM3—epilepsy syndrome	6.88e-06	3.94e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—KCNJ11—epilepsy syndrome	6.88e-06	3.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCG2—epilepsy syndrome	6.02e-06	3.45e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2C19—epilepsy syndrome	5.87e-06	3.36e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP11A1—epilepsy syndrome	5.83e-06	3.34e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—epilepsy syndrome	5.7e-06	3.27e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCG2—epilepsy syndrome	5.61e-06	3.22e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2C19—epilepsy syndrome	5.47e-06	3.13e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP11A1—epilepsy syndrome	5.43e-06	3.11e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	5.26e-06	3.02e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.02e-06	2.88e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	5.01e-06	2.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—epilepsy syndrome	4.99e-06	2.86e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2D6—epilepsy syndrome	4.9e-06	2.81e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—epilepsy syndrome	4.77e-06	2.74e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	4.76e-06	2.73e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	4.71e-06	2.7e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TH—epilepsy syndrome	4.69e-06	2.69e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	4.68e-06	2.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ADRA2A—epilepsy syndrome	4.67e-06	2.68e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—epilepsy syndrome	4.65e-06	2.66e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—epilepsy syndrome	4.43e-06	2.54e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLCB1—epilepsy syndrome	4.39e-06	2.51e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TH—epilepsy syndrome	4.37e-06	2.5e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	3.91e-06	2.24e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAT—epilepsy syndrome	3.86e-06	2.21e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	3.76e-06	2.15e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	3.65e-06	2.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAT—epilepsy syndrome	3.6e-06	2.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	3.5e-06	2.01e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—epilepsy syndrome	3.49e-06	2e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—epilepsy syndrome	3.25e-06	1.87e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—epilepsy syndrome	3.06e-06	1.76e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—epilepsy syndrome	3e-06	1.72e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.85e-06	1.64e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.8e-06	1.6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—POMC—epilepsy syndrome	2.58e-06	1.48e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—POMC—epilepsy syndrome	2.4e-06	1.38e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—epilepsy syndrome	2.35e-06	1.35e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.19e-06	1.26e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	2.06e-06	1.18e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	1.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.03e-06	5.92e-06	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—epilepsy syndrome	9.63e-07	5.52e-06	CbGpPWpGaD
